Assessment of pain and impact of care among patients with painful diabetic peripheral neuropathy

被引:12
作者
Schumacher, Christie [1 ]
Glosner, Scott E. [2 ]
机构
[1] Midwestern Univ, Chicago Coll Pharm, Downers Grove, IL 60515 USA
[2] Pfizer Inc, Elmhurst, IL USA
关键词
Diabetic peripheral neuropathy; quality of life diabetes; PREVALENCE; SEVERITY; BURDEN; IDENTIFICATION; MANAGEMENT; ILLNESS;
D O I
10.1331/JAPhA.2014.13049
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: To assess the prevalence of painful diabetic peripheral neuropathy (DPN), evaluate the impact of DPN on patients' function and quality of life, and assess patient satisfaction with their current DPN treatment. Design: Cross-sectional study. Setting: Patient-centered medical home model at an internal medicine clinic in Chicago, from November 1, 2011, through November 1, 2012. Participants: 71 patients with type 1 or type 2 diabetes aged 45 to 85 years and receiving diabetes education and medication management from the clinic pharmacist. Intervention: Paper survey administered to patients during clinic visits. Main outcome measures: DPN history; DPN impact on activity level, sleep, and quality of life; and satisfaction with current DPN treatment. Results: Of the 71 participants, 22% (n = 15) reported a diagnosis of DPN from their providers; however, 54% (n = 37) reported burning, aching, or tenderness in their hands, arms, legs, or feet. More than 50% of patients with these symptoms had experienced them for more than 1 year. Fewer than one in five patients (14% [n = 5]) reporting symptoms indicative of painful DPN were receiving treatment. Conclusion: DPN may be underdiagnosed and undertreated in this patient population, which represents a potential opportunity for pharmacists to help patients with diabetes meet their quality of care goals.
引用
收藏
页码:14 / +
页数:7
相关论文
共 19 条
[1]  
Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc12-s011]
[2]  
[Anonymous], 2008, NAT DIAB FACT SHEET
[3]   Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: A review [J].
Barrett, Amy M. ;
Lucero, Melanie A. ;
Le, Trong ;
Robinson, Rebecca L. ;
Dworkin, Robert H. ;
Chappell, Amy S. .
PAIN MEDICINE, 2007, 8 :S50-S62
[4]   Diabetic neuropathies - A statement by the American Diabetes Association [J].
Boulton, AJM ;
Vinik, AI ;
Arezzo, JC ;
Bril, V ;
Feldman, EL ;
Freeman, R ;
Malik, RA ;
Maser, RE ;
Sosenko, JM ;
Ziegler, D .
DIABETES CARE, 2005, 28 (04) :956-962
[5]   Diabetic somatic neuropathies [J].
Boulton, AJM ;
Malik, RA ;
Arezzo, JC ;
Sosenko, JM .
DIABETES CARE, 2004, 27 (06) :1458-1486
[6]   The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes [J].
Davies, Mark ;
Brophy, Sinead ;
Williams, Rhys ;
Taylor, Ann .
DIABETES CARE, 2006, 29 (07) :1518-1522
[7]   THE PREVALENCE BY STAGED SEVERITY OF VARIOUS TYPES OF DIABETIC NEUROPATHY, RETINOPATHY, AND NEPHROPATHY IN A POPULATION-BASED COHORT - THE ROCHESTER DIABETIC NEUROPATHY STUDY [J].
DYCK, PJ ;
KRATZ, KM ;
KARNES, JL ;
LITCHY, WJ ;
KLEIN, R ;
PACH, JM ;
WILSON, DM ;
OBRIEN, PC ;
MELTON, LJ .
NEUROLOGY, 1993, 43 (04) :817-824
[8]   Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep [J].
Gore, M ;
Brandenburg, NA ;
Dukes, E ;
Hoffman, DL ;
Tai, KS ;
Stacey, B .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2005, 30 (04) :374-385
[9]   Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice [J].
Gore, Mugdha ;
Dukes, Ellen ;
Rowbotham, David J. ;
Tai, Kei-Sing ;
Leslie, Douglas .
EUROPEAN JOURNAL OF PAIN, 2007, 11 (06) :652-664
[10]   Burden of illness in painful diabetic peripheral neuropathy: The patients' perspectives [J].
Gore, Mugdha ;
Brandenburg, Nancy A. ;
Hoffman, Deborah L. ;
Tai, Kei-Sing ;
Stacey, Brett .
JOURNAL OF PAIN, 2006, 7 (12) :892-900